A new class of drugs that combine artificial DNA structures with antibodies could make immunotherapies even more targeted—all you have to do is fold over and over again. In a study published Aug. 17 ...
Trying to document how single brain cells participate in networks that govern behavior is a daunting task. Brain probes called Neuropixels, which feature high-density silicon arrays, have enabled ...